This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Designing an IHC experiment for Adenylate cyclase type 9? The guide has the expected staining pattern, antigen retrieval and fixation, antibodies backed by real IHC images, the tissue controls to run alongside, and protocols taken from published papers.
Open the ADCY9 IHC GuideFacts about Adenylate cyclase type 9.
.
| Human | |
|---|---|
| Gene Name: | ADCY9 |
| Uniprot: | O60503 |
| Entrez: | 115 |

| Belongs to: |
|---|
| adenylyl cyclase class-4/guanylyl cyclase family |

adenylate cyclase type 9; AC9; adenylate cyclase 9
Mass (kDA):
150.701 kDA

| Human | |
|---|---|
| Location: | 16p13.3 |
| Sequence: | 16; NC_000016.10 (3953387..4116442, complement) |
Detected in skeletal muscle, pancreas, lung, heart, kidney, liver, brain and placenta (PubMed:9628827, PubMed:10987815). Expressed in multiple cells of the lung, with expression highest in airway smooth muscle (PubMed:12972952).
Cell membrane; Multi-pass membrane protein.





PMID: 9628827 by Hacker B.M., et al. Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9).
PMID: 12972952 by Small K.M., et al. An Ile to Met polymorphism in the catalytic domain of adenylyl cyclase type 9 confers reduced beta2-adrenergic receptor stimulation.